May 15, 2021 01:00 PM
India Biotech will set up new units in Karnataka and Maharashtra for the production of Covid-19 vaccine ‘covaxin’. Karnataka Deputy Chief Minister CN Ashwat Narayan has said that a biotech vaccine manufacturing unit is coming up at Malur Industrial Estate near Kolar near Bangalore.
He explained that the project has been approved by the state government and construction work has started. He said their idea was to start making vaccines here as soon as possible.
The state government will provide all kinds of assistance for this. He also said that the place is close to the city of Bangalore and the traffic is easy.
Similarly, India Biotech is preparing to manufacture ‘covaxin’ vaccine in Pune, Maharashtra. Biowet Pvt Ltd, a subsidiary of India Biotech, will open a vaccine manufacturing unit in Pune, Maharashtra by August, state government officials said.
Pune Divisional Commissioner Saurabh Rao and District Collector Rajesh Deshmukh visited the 12-hectare site where the Indian Vaccine Manufacturing Unit will be set up in the Manjari Khurd area of Pune. The site, owned by Intervet India Pvt Ltd, a subsidiary of Merck & Co., has long been unused and the Bombay High Court has allowed Indian biotech to use it for the manufacture of vaccines. Saurabh Rao explained that all the facilities are here, so the preparation of vaccines can be started immediately. Representatives of Biowet Pvt Ltd are also scrutinizing the site.
They stated that all precautions should be taken as vaccine preparation is a very complex process. Saurabh Rao said the vaccine was expected to be ready by the end of August.
He said the central government and the Maharashtra government were ready to give all the permits soon. Intervet India Pvt. Ltd. selected the site in 1973 for the manufacture of FMD (Foot and Mouth Disease) vaccines and undertook some construction. But with the decision to discontinue business activities in our country no manufacturing activities are being conducted here.